HEADER DNA 11-DEC-06 2E4I TITLE HUMAN TELOMERIC DNA MIXED-PARALLEL/ANTIPARALLEL QUADRUPLEX UNDER TITLE 2 PHYSIOLOGICAL IONIC CONDITIONS STABILIZED BY PROPER INCORPORATION OF TITLE 3 8-BROMOGUANOSINES COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA (5'-D(*DAP*(BGM)P*DGP*DGP*DTP*DTP*DAP*(BGM) COMPND 3 P*DGP*DGP*DTP*DTP*DAP*(BGM)P*(BGM)P*DGP*DTP*DTP*DAP*(BGM)P*DGP*DG)- COMPND 4 3'); COMPND 5 CHAIN: A; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: HUMAN TELOMERIC DNA SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS TELOMERE, QUADRUPLEX, MIXED-PARALLEL/ANTIPARALLEL, DNA EXPDTA SOLUTION NMR AUTHOR A.MATSUGAMI,Y.XU,Y.NOGUCHI,H.SUGIYAMA,M.KATAHIRA REVDAT 3 09-MAR-22 2E4I 1 REMARK LINK REVDAT 2 24-FEB-09 2E4I 1 VERSN REVDAT 1 11-DEC-07 2E4I 0 JRNL AUTH A.MATSUGAMI,Y.XU,Y.NOGUCHI,H.SUGIYAMA,M.KATAHIRA JRNL TITL STRUCTURE OF A HUMAN TELOMERIC DNA SEQUENCE STABILIZED BY JRNL TITL 2 8-BROMOGUANOSINE SUBSTITUTIONS, AS DETERMINED BY NMR IN A K+ JRNL TITL 3 SOLUTION JRNL REF FEBS J. V. 274 3545 2007 JRNL REFN ISSN 1742-464X JRNL PMID 17561958 JRNL DOI 10.1111/J.1742-4658.2007.05881.X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 2.4, X-PLOR 3.851 REMARK 3 AUTHORS : F. DELAGLIO (NMRPIPE), A.T. BRUNGER (X-PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURES ARE BASED ON A TOTAL OF 752 RESTRAINTS, 582 ARE NOE- REMARK 3 DERIVED REMARK 3 DISTANCE CONSTRAINTS, 110 DIHEDRAL ANGLE RESTRAINTS,48 DISTANCE REMARK 3 RESTRAINTS REMARK 3 FROM HYDROGEN BONDS, 12 PLANARITY RESTRAINTS FOR TETRAD PLANES. REMARK 4 REMARK 4 2E4I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000026214. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.3 REMARK 210 IONIC STRENGTH : 110MM POTASSIUM ION REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.6MM DNA; 100MM KCL; 10MM K REMARK 210 -PHOSPHATE (PH 6.3); 0.01MM DSS, REMARK 210 100% D2O; 0.6MM DNA; 100MM KCL; REMARK 210 10MM K-PHOSPHATE (PH 6.3); REMARK 210 0.01MM DSS, 95% H2O, 5% D2O; REMARK 210 1.3MM DNA; 100MM KCL; 10MM K- REMARK 210 PHOSPHATE (PH 6.3); 0.01MM DSS, REMARK 210 95% H2O, 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; DQF-COSY; JR REMARK 210 -HMBC; 13C-HSQC; H, P HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5, PIPP 4.3.2, SPAKY REMARK 210 3.112, X-PLOR 3.851 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 2E4I A 1 22 PDB 2E4I 2E4I 1 22 SEQRES 1 A 22 DA BGM DG DG DT DT DA BGM DG DG DT DT DA SEQRES 2 A 22 BGM BGM DG DT DT DA BGM DG DG MODRES 2E4I BGM A 2 DG MODRES 2E4I BGM A 8 DG MODRES 2E4I BGM A 14 DG MODRES 2E4I BGM A 15 DG MODRES 2E4I BGM A 20 DG HET BGM A 2 33 HET BGM A 8 33 HET BGM A 14 33 HET BGM A 15 33 HET BGM A 20 33 HETNAM BGM 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE FORMUL 1 BGM 5(C10 H13 BR N5 O7 P) LINK O3' DA A 1 P BGM A 2 1555 1555 1.61 LINK O3' BGM A 2 P DG A 3 1555 1555 1.61 LINK O3' DA A 7 P BGM A 8 1555 1555 1.61 LINK O3' BGM A 8 P DG A 9 1555 1555 1.61 LINK O3' DA A 13 P BGM A 14 1555 1555 1.61 LINK O3' BGM A 14 P BGM A 15 1555 1555 1.61 LINK O3' BGM A 15 P DG A 16 1555 1555 1.61 LINK O3' DA A 19 P BGM A 20 1555 1555 1.61 LINK O3' BGM A 20 P DG A 21 1555 1555 1.61 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000